New Toolkit Helps Community Pharmacies Launch Harm Reduction Services
A new toolkit from the University of Pittsburgh School of Pharmacy offers community pharmacies a practical, step-by-step guide to implementing harm reduction services — from assembling supply kits and training staff to marketing services and integrating them into existing workflows. Here's why it matters for pharmacist-led OUD care.
Pharmacists Are Critical In Opioid Use Disorder Care - Pharmacy Practice News
The SUPPORT for Patients and Communities Reauthorization Act, signed into law in 2025, grants pharmacists greater autonomy to prescribe buprenorphine for opioid use disorder after completing specialized training. In a new article in Pharmacy Practice News, two clinical pharmacists describe how they are already providing OUD care across VA, hospital, and community settings — and why state scope-of-practice laws must evolve to match what federal law now permits.